László Herszényi
Impact in
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
-
- Gastroesophageal reflux and treatments 12
-
- Protease and Inhibitor Mechanisms 13
- Co-authors
- Zsolt Tulassay (53 shared papers)Pál Miheller (22 shared papers)István Hritz (14 shared papers)Gábor Lakatos (10 shared papers)Fabio Farinati (16 shared papers)Zsolt Tulassay (7 shared papers)Mária Zsófia Varga (4 shared papers)Romilda Cardin (13 shared papers)
In The Last Decade
László Herszényi
93 papers receiving 2.5k citations
László Herszényi's Hit Papers
Peers
Comparison fields: 5 of 112
- Gastroenterology 271
- Cancer Research 489
- Genetics 506
- Oncology 445
- Surgery 572
Countries citing papers authored by László Herszényi
This map shows the geographic impact of László Herszényi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Herszényi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Herszényi more than expected).
Fields of papers citing papers by László Herszényi
This network shows the impact of papers produced by László Herszényi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Herszényi. The network helps show where László Herszényi may publish in the future.
Co-authors
The 25 scholars most cited alongside László Herszényi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiology of gastrointestinal and liver tumors. | 2010 | 341 |
| 2 | Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial Hit paper breakdown → | 2022 | 236 |
| 3 | 2012 | 127 | |
| 4 | 2021 | 127 | |
| 5 | 2009 | 109 | |
| 6 | 2008 | 88 | |
| 7 | 2011 | 83 | |
| 8 | 2012 | 75 | |
| 9 | 2011 | 69 | |
| 10 | 1996 | 62 | |
| 11 | 2014 | 62 | |
| 12 | 2007 | 61 | |
| 13 | 2007 | 57 | |
| 14 | 2011 | 53 | |
| 15 | 2000 | 48 | |
| 16 | 2014 | 47 | |
| 17 | 2007 | 47 | |
| 18 | 2018 | 47 | |
| 19 | 2019 | 46 | |
| 20 | 1995 | 44 |
About László Herszényi
László Herszényi is a scholar working on Gastroenterology, Cancer Research, Oncology, Surgery and Epidemiology, having authored 94 papers that have together received 2.6k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (16 papers), Protease and Inhibitor Mechanisms (13 papers), Gastroesophageal reflux and treatments (12 papers), Inflammatory Bowel Disease (12 papers), Gastric Cancer Management and Outcomes (11 papers), Microscopic Colitis (9 papers), Eosinophilic Esophagitis (8 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Gastroenterology (271 citations), Cancer Research (489 citations), Genetics (506 citations), Oncology (445 citations) and Surgery (572 citations). László Herszényi has collaborated with scholars based in Hungary, Italy and Germany. Frequent co-authors include Zsolt Tulassay, Pál Miheller, István Hritz, Gábor Lakatos, Fabio Farinati, Zsolt Tulassay, Mária Zsófia Varga, Romilda Cardin, Márk Félix Juhász and Mario Plebani. Their work appears in journals such as Digestive Diseases, European Journal of Cancer Prevention, Pathology & Oncology Research, Scandinavian Journal of Gastroenterology and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.